Abstract Elevated plasma free fatty acid (FFA) level is common in many pathological conditions, including neurological disorders, and their deleterious effects on various cells have been well documented. However, it remains to be investigated whether elevated FFAs would have a direct effect on neural stem cells (NSCs). Here, we reported that palmitic acid (PA) impaired cell viability and increased apoptosis of NSCs significantly in a dose-and time-dependent manner. Increased protein levels of Bax and cleaved caspase 3 coupled with decreased expression of Bcl-2 were also observed in NSCs with increasing dose or time of PA treatment, whereas caspase 3 expression remained relatively unaltered. In parallel to this, the expression of phospho-c-Jun N-terminal kinase (p-JNK) in NSCs challenged with PA was increased significantly; however, JNK expression appeared stable. Remarkably, JNK inhibitor effectively reduced the apoptosis of NSCs induced by PA. The expression of phospho-p38 (p-p38), p38, Abbreviations: BSA, bovine serum albumin; DAPI, 4′, 6-diamidino-2-phenylindole; E13.5, embryonic day 13.5; ERK1/2, extracellular regulated protein kinase 1/2; FFAs, free fatty acids; GFAP, glial fibrillary acidic protein; JNK, c-Jun N-terminal kinase; MAP2, microtubule-associated protein 2; MAPKs, mitogen-activated protein kinases; MTT, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; NSCs, neural stem cells; PA, palmitic acid; p-ERK1/2, phospho-extracellular regulated protein kinase 1/2; p-JNK, phospho-c-Jun N-terminal kinase; p-p38, phospho-p38; SA, stearic acid; TUNEL, terminal deoxynucleotidyttransferase-mediated dUTP nick ending labeling. phospho-extracellular regulated protein kinases 1/2 (p-EKR1/2) and EKR1/2 in NSCs was not affected by PA treatment. In consideration of the above, it is suggested that elevated plasma FFA level may induce apoptosis of NSCs in vivo, and that this might be one of possible underlying mechanisms for the cognitive disturbance in neurological disorders.
Introduction
Free fatty acids (FFAs), including saturated and unsaturated FFAs, are the major source of lipid energy in human body and released mainly from adipose tissue by lipolysis of triglycerides (Miles and Nelson, 2007) . FFAs circulating in the plasma are largely bound to the albumin, with a concentration of~0.1 to 1.0 mM. Lipotoxicity follows when non-adipose cells are exposed to chronic elevation of FFAs, which can result from disturbed balance between release and clearance of FFAs, e.g., on a high fat diet or under other metabolic conditions (Mittendorfer, 2011; Boden, 2008) . Besides fatty acids trafficking alterations, high level of FFAs may also be a consequence of membrane phospholipid degradation caused by activated phospholipases in many pathological conditions, such as trauma, hypoxia and stroke (Farooqui and Horrocks, 1998) . It has been reported that FFAs accumulated acutely after traumatic brain injury, with the concentration of palmitic acid (PA) in the brain increasing from~60 to 180 μM and stearic acid (SA) from~50 to 350 μM (Lipton, 1999) . Moreover, elevated plasma FFA level can inhibit insulin's anti-lipolytic action which further increases the release of FFAs into circulation (Boden, 2008) .
Pathological accumulation of saturated FFAs in the human body can pose serious threat to normal cellular homeostasis, which has been suggested to be involved in the development of many chronic diseases, such as obese, diabetes and cardiovascular diseases (Gomez-Lechon et al., 2007; Saunders et al., 2008) . Importantly, brain could uptake FFAs from plasma through the blood-brain barrier (Wang et al., 1994) . In other words, elevated FFA level can exacerbate cellular damage directly on brain, leading to different extent of cognitive decline and brain abnormalities (Adibhatla and Hatcher, 2008) . In addition, excessive saturated FFAs could freely penetrate placental barrier, thereby interfering with the development and growth of embryos, including the development of brain (Yu et al., 2009; Elahi et al., 2009; Tozuka et al., 2009) . These data suggest that FFAs can readily enter and exert their destructive effects on the brain.
There is growing evidence indicating that the deleterious effects of saturated FFAs on the brain have been associated with alterations of its cells. Cell death was obvious when nerve growth factor-differentiated PC12 cells were exposed to FFAs, such as SA and PA (Ulloth et al., 2003; Almaguel et al., 2009 ). FFAs exerted Alzheimer-like pathological effects on neurons through their actions on primary rat cortical astroglia (Patil et al., 2007) . Neural stem cells (NSCs), residing in both fetal and adult brain, have been suggested to differentiate into various kinds of neurons and astrocytes and play important roles in the development and injuries repair of the brain (Temple, 2001; Alvarez-Buylla et al., 2002; Kim, 2004) . Many factors have been shown to exert their effects on NSCs, influencing their proliferation, apoptosis and differentiation (Gao and Gao, 2007; Anthony et al., 2008) . However, there is an apparent lack of information about the effects of saturated FFAs on NSCs. In view of this, it is desirable to explore the effects of elevated saturated FFAs on NSCs, as this might offer a possible explanation for the cognitive alterations and brain abnormalities of neurological disorders due to elevation of FFAs. In the present study, we have employed suspension culture to obtain mouse NSCs in vitro in the form of neurospheres. We next investigated the impact of PA, the most abundant saturated fatty acid in the diet or in the plasma, on NSCs in vitro with an aim to gain a further understanding of the underlying molecular mechanism of its effects on the stem cells.
Materials and methods
All experiments were carried out in accordance with "the National Institute of Health Guide for the Care and Use of Laboratory Animals revised 1996", which is also adopted by the Laboratory Animal Center, Shandong University. All efforts were made to minimize the pain and suffering of mice during all the procedures.
Primary culture of embryonic NSCs
Embryos of Kung Ming mouse (purchased from Laboratory Animal Center, Shandong University) at E13.5 were collected by Cesarean section of pregnant mice, and then the telencephalons of the embryos were isolated and mechanically disrupted into single cells by repeated pipetting in a serum free DMEM/F12 (1:1) medium (Invitrogen, Carlsbad, CA, USA) for three times. After being filtered, cell number was counted and cells were seeded at 5 × 10 5 cells/ml in DMEM/F12 (1:1) medium supplemented with 2% B27 (Gibco, Gaithersburg, MD, USA), 20 ng/ml basic fibroblast growth factor (R&D, Minneapolis, MN, USA), 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA) and 100 μg/ml streptomycin (Sigma-Aldrich) in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. After 5 days of culture, neuropheres were harvested by centrifugation, dissociated using trypsin and EDTA (Sigma-Aldrich), and re-seeded for following experiments.
Characterization of NSCs
For examination of NSC specific marker, neurospheres were seeded on coverslips and cultured for 24 h before fixation. For proliferation of NSCs, dissociated NSCs were seeded on coverslips and cultured for 3 days and supplemented with BrdU 4 h before fixed. To examine the differentiation of NSCs, dissociated NSCs were seeded on coverslips, added with differentiation medium (containing 2% fetal bovine serum without growth factors) and cultured for 5 days. After fixation, cells on coverslips were incubated with mouse anti-Nestin monoclonal antibody (1:500; Millipore, Billerica, MA, USA), mouse anti-BrdU monoclonal antibody (1:1000; Sigma-Aldrich), mouse anti-microtubule-associated protein 2 (MAP2) monoclonal antibody (1:200; Millipore) or mouse anti-glial fibrillary acidic protein (GFAP) monoclonal antibody (1:500; Millipore). FITC-or TRITC-conjugated goat anti-mouse IgG (1:200; Millipore) was used as secondary antibodies. Cell nuclei were counterstained with 4′, 6-diamidino-2-phenylindole (DAPI, 5 μg/ml; Vector Laboratories, Burlingame, CA, USA) and photoimages were captured using a fluorescence microscope (Olympus, Tokyo, Japan).
Preparation of PA-albumin complexes PA (Sigma-Aldrich) was first dissolved in 100% ethanol at 70°C. Then PA was mixed with fatty acid-free and low endotoxin bovine serum albumin (BSA, Sigma-Aldrich) at 50°C for a final PA concentration of 25-200 mM as described before (Lee et al., 2001) . The stock solutions were sterilized by filtering and stored at −20°C. The control group receiving ethanol and BSA without PA was similarly prepared. Fresh working solutions were prepared each time by diluting different concentrations of stock solutions in DMEM/F12 (1:1) medium, with all the final PA solutions containing the same amount of BSA.
Cell viability assay
Cell viability of NSCs was assessed by employing the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (Sartorius, Goettingen, Germany) assay. Briefly, dissociated NSCs were seeded onto 96-well culture plate at a density of 5000 cells per well and cultured in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. After culturing for 24 h, the medium was aspirated out, and cells were treated with various concentrations of PA (0, 50, 100, 200, 400 and 800 μM) for 24 h or 48 h. Four hours before the end of 24 h or 48 h incubation, 5 mg/ml MTT with a volume of 20 μl was added to each well and further incubation was continued until 24 h or 48 h. Then the medium was carefully removed, and each well was added with 200 μl DMSO to lyse the formazan crystals. The absorbance value of each sample was immediately determined with a multi-well spectrophotometer (Bio-Rad Laboratories, Shanghai, PR China) at 490 nm. Three independent experiments were conducted.
Morphological observations
Passaged NSCs were seeded into culture flask at a density of 5×10 5 cells/ml and cultured for 2-4 days to form neuropheres. The neurospheres were then seeded on coverslips in 12-well culture plate and treated with various concentrations of PA (0, 50, 100, 200, 400 and 800 μM) for 48 h. Images were captured with a light microscope (Olympus).
TUNEL assay
Dissociated NSCs were seeded on coverslips in 12-well culture plate. After cultured for 2-4 days, each well was added with different concentrations of PA (0, 50, 100, 200 and 400 μM) for 48 h or with 400 μM PA for different time durations (12, 24, 36 and 48 h) . In situ cell apoptosis caused by PA was determined using terminal deoxynucleotidyttransferase-mediated dUTP nick ending labeling (TUNEL) staining (Roche Applied Science, Mannheim, Germany). Briefly, after fixation and permeabilization, cells on coverslips were incubated with TUNEL reaction mixture including terminal deoxynucleotidyl transferase and fluorescein-labeled nucleotides in a humidified atmosphere for 1 h at 37°C in the dark and were then counterstained with DAPI. Analysis by fluorescence microscope was carried out. Three independent experiments were conducted.
Western blot analysis
Passaged NSCs were seeded into culture flask at a density of 5×10 5 cells/ml and cultured for 2-4 days, and then added with different concentrations of PA (0, 50, 100, 200 and 400 μM) for 48 h or with 400 μM PA for different times (12, 24, 36 and 48 h) . After that, cells were collected, washed with cold PBS and lysed in cold 1 × lysis buffer supplemented with protease inhibitors. The lysates were centrifuged and supernatants were collected. Protein concentrations in the supernatants were then measured using a BCA protein assay kit (Pierce Biotechnology, Rockford, IL, USA). Equal amounts of protein (20 μg for each sample) were separated on SDS-PAGE and electrotransferred onto a polyvinylidene fluoride membrane (0.45 μm, Millipore). After being rinsed in TBST solution and blocking in 5% nonfat milk, the membranes were subsequently probed with Bax (1:1000; Santa Cruz Biotechnology, Inc., CA, USA), Bcl-2 (1:1000; Santa Cruz Biotechnology, Inc.), cleaved caspase-3 (1:1000; Cell Signaling Technology, Boston, MA, USA), caspase 3 (1:1000; Cell Signaling Technology), phospho-p38 mitogen-activated protein kinase (p-p38 MAPK) (1:1000; Cell Signaling Technology), p38 MAPK (1:1000; Cell Signaling Technology), phospho-c-Jun N-terminal kinase (p-JNK) (1:1000; Cell Signaling Technology), c-Jun N-terminal kinase (JNK) (1:1000; Cell Signaling Technology), phospho-extracellular regulated protein kinase 1/2 (p-ERK1/2) (1:1000; Cell Signaling Technology), extracellular regulated protein kinase 1/2 (ERK1/2) (1:1000; Cell Signaling Technology) and β-actin (1:1000; Sigma-Aldrich) antibodies and were finally visualized by the enhanced chemiluminescence system (Millipore). After developing and fixing, the intensity of bands on the films was quantified and analyzed by the Image J software. Three independent experiments were carried out.
JNK inhibitor administration
NSCs cultured for 2-4 days on coverslips or in culture flask were challenged with 50 μM JNK inhibitor SP600125 (SigmaAldrich) for 1 h, followed by 400 μM PA treatment for 48 h. The apoptosis of NSCs was then determined by TUNEL assay or western blot analysis.
Statistical analysis
All quantitative data were input into SPSS 11.5 software, expressed as mean ± SD and analyzed by Student's t test. Differences were considered as significant at P b 0.05.
Results
Effects of PA on cell viability of NSCs were dose-and time-dependent NSCs were isolated from telencephalons of mouse embryos at embryonic day 13.5 (E13.5) and grown in the form of neurospheres. As shown in Fig. S1 , almost all cells in the neurospheres were Nestin-positive, and the dissociated NSCs could incorporate BrdU and differentiate into MAP2-positive neurons and GFAP-positive astrocytes. All these results confirmed the identity of the NSCs. Following the characterization of the NSCs, we employed the MTT assay to evaluate the effect of different doses of PA on cell viability. As shown in Fig. 1A , PA evidently impaired the cell viability of NSCs in a dose-dependent manner at 24 h and 48 h, especially at the concentration of 200 μM, 400 μM and 800 μM (91.14 ± 8.50%, 50.30 ± 6.46% and 29.71 ± 5.37% of control group for 24 h, and 80.50 ± 7.18%, 39.10 ± 5.86% and 17.63 ± 2.45% of control group for 48 h). In addition, we also examined the cell viability difference of PA treatment (400 μM) between 24 h and 48 h. Compared with the results at 24 h, cell viability of NSCs at 48 h was decreased significantly from the dose of PA at 200 μM to 800 μM (Fig. 1A) .
We next examined the morphological alterations of NSCs treated with different doses of PA at 48 h under the light microscope. Noticeable changes were observed among these groups (Fig. 1B) . Neurospheres in the control and 50 μM PA groups appeared to grow well. The peri-neurosphere region was surrounded by a large number of cells. When neurospheres were treated with 100 μM or 200 μM PA, the cells around neurospheres were markedly reduced. At 400 μM PA, the containing cells in the neurospheres were drastically reduced, in which only occasional cells were detected. At 800 μM PA, the cells inside the neurospheres were hardly detected.
PA induced apoptosis of NSCs
Due to the decreased cell viability and evident morphological alterations with PA supplementation, we next sought to determine the incidence of apoptosis of NSCs challenged with PA. Results showed that more TUNEL-positive cells occurred in clusters at a higher dose of PA at 48 h, especially at the concentrations of 200 μM and 400 μM PA (Fig. 2) . In addition, prolonged PA treatment resulted in a higher percentage of apoptotic cells (Fig. 3) .
Along with the above, we examined the expression of some classical proteins associated with cell apoptosis in NSCs with PA treatment, including Bax, Bcl-2, cleaved caspase 3 and caspase 3. Western blot assay showed that the protein level of Bax was significantly elevated, while the expression of Bcl-2 was markedly decreased, as the concentration or treatment time of PA on NSCs was increased (Fig. 4A) . The ratio of Bax and Bcl-2 protein was elevated significantly as the dose of PA was increased (Fig. 4B) or the duration of PA treatment extended (Fig. 4C) . Moreover, when NSCs were treated with a higher dose of PA, the protein level of cleaved caspase 3 was concomitantly elevated. On the other hand, there was no obvious difference in caspase 3 expression among all groups (Fig. 4A) . Besides being dose-dependent, cleaved caspase-3 expression in NSCs following PA treatment showed a steady increase in a time-dependent manner; however, expression of caspase 3 remained relatively unchanged (Fig. 4A) . It is noteworthy that the ratio of cleaved caspase 3 and caspase 3 proteins followed a similar expression trend at a higher dose or longer duration of PA treatment (Figs. 4D and E).
MAPK pathway was involved in the increased apoptosis of NSCs induced by PA
To further investigate the mechanisms of PA on apoptosis of NSCs, we next examined the expression of MAPKs, which have been well documented to be involved in the regulation of cell proliferation, apoptosis and differentiation. It was found that with the increase in concentration of PA treatment in NSCs, the protein level of p-JNK was elevated significantly; however, the expression of JNK was relatively stable at different PA doses (Figs. 5A and B) . Likewise, the expression of p-p38, p38, p-ERK1/2 and ERK1/2 in NSCs with different doses of PA treatment remained relatively unaltered (Figs. 5A, C and D) . We also examined the expression of p-JNK, p-p38 and p-EKR1/2 in NSCs with PA treatment for different time periods. In prolonged PA treatment, the protein level of p-JNK was substantially increased, but JNK expression remained relatively constant (Figs. 6A and B) . In addition, there were no obvious changes in the expression of p-p38, p38, p-ERK1/2 and ERK1/2 in NSCs with different time duration of PA treatment (Figs. 6A, C and D) . These results suggest that increased 
Increased apoptosis of NSCs induced by PA was JNK dependent
In order to verify whether p-JNK signaling was responsible for regulating apoptosis of NSCs induced by PA, SP600125, a selective JNK inhibitor, was applied to NSCs cultures 1 h before PA treatment. As shown in Figs. 7A and B, SP600125 significantly attenuated PA-induced apoptosis in NSCs. Concurrently, the expression of Bax, Bcl-2, cleaved caspase-3 and caspase 3 was also affected greatly with the application of JNK inhibitor in NSCs before challenged with PA (Figs. 7C-E) , i.e., the protein levels of Bax and cleaved caspase 3 were obviously elevated, while that of Bcl-2 was greatly reduced. There was no obvious alteration in caspase 3 expression.
Compared with the PA group, the ratio of Bax and Bcl-2 or cleaved caspase 3 and caspase 3 was clearly decreased after administration of JNK inhibitor.
Discussion
Here, we reported that exposure of NSCs to PA promoted apoptosis, upregulated the protein levels of Bax and cleaved caspase 3 and reduced the expression of Bcl-2 in a dose-and time-dependent way. Furthermore, we found that JNK signaling was involved in mediating PA-induced apoptosis of NSCs.
Elevated FFA level has been associated with the development of many pathological conditions including neurological disorders. For instance, elevation of FFAs has been suggested to be a risk factor of Alzheimer's disease, with neurons and astrocytes being affected, which might be responsible for the cognitive decline in the brain (Patil et al., 2006 (Patil et al., , 2008 . Cognitive abilities, such as learning and memory, depend on neurogenesis in the brain, which is involved in the proliferation, apoptosis and differentiation of NSCs and can be influenced by many stimuli (Fike, 2011; Tesone-Coelho et al., 2012; Lindqvist et al., 2006; Gao and Gao, 2007) . Plasma saturated FFAs, such as SA and PA, could bring about deleterious effects on many cell types, with apoptosis being the most common phenomenon (Jiang et al., 2010; Wang et al., 2010; Malhi et al., 2006; Welters et al., 2006; Almaguel et al., 2009; Ricchi et al., 2009) . Therefore, it is worthy to explore whether elevated saturated FFA level would also influence the apoptosis of NSCs. In the present study, we have chosen PA as a representative saturated fatty acid, to explore its effects on NSCs.
As expected, PA could decrease the viability of NSCs in a dose-and time-dependent manner. In addition to its adverse effects on cell morphology, our speculation that PA might also be involved in apoptosis of NSCs was confirmed by TUNEL assay. Very interestingly, the effects of PA on apoptosis of NSCs were dose-and time-dependent, indicating that the severity of neurological disorders might be associated with different extent of PA elevation. Bcl-2, an anti-apoptotic protein of Bcl-2 family, was identified in blocking apoptosis rather than promoting proliferation (Korsmeyer et al., 1993) . It is expressed restrictedly in progenitor cells, long-lived cells and extensively in the developing embryo (Korsmeyer et al., 1993) . Bax can heterodimerize in vivo with Bcl-2 and accelerate cell apoptosis (Korsmeyer et al., 1993) . Moreover, the ratio of Bax and Bcl-2 appears to determine the survival or cell death following an apoptotic stimulus (Korsmeyer et al., 1993) , i.e., a high ratio of Bax and Bcl-2 indicates apoptosis. We show here that the expression of Bax was increased and that of Bcl-2 decreased in the NSCs following PA treatment. The increase in the ratio of Bax and Bcl-2 further verified the apoptosis of NSCs caused by PA. Moreover, the Bcl-2 family, acts as a checkpoint upstream of caspases (Burlacu, 2003) , which are the key executioners of apoptosis and exert their actions by the way of cleavage. Caspase 3 is one of the caspases and the cleavage of caspase 3 leads to the formation of cleaved caspase 3 whose elevation has been suggested to promote cell apoptosis (Porter and Janicke, 1999) . The parallel increase in the expression of cleaved caspase 3 and Bax/Bcl-2 in the present study suggests that the alterations of cleaved caspase 3 may be mediated by the Bax and Bcl-2 expression. This would further support our view of the effects of PA on apoptosis of NSCs. In short, alterations of cell apoptosis and associated proteins in NSCs by PA treatment suggest that PA switches on the irreversible process of apoptosis and ultimately leads to apoptosis of NSCs.
The MAPKs, consist of p38s, JNKs and ERKs, are a family of protein kinases and exert their actions in form of phosphorylation. JNK signaling is widely involved in cell apoptosis caused by various stimuli (Davis, 2000) . Besides, JNK is required for embryonic morphogenesis (Davis, 2000) and can be activated by raised plasma FFA level, many of which were related to PA (Jiang et al., 2010; Boden et al., 2005; Hotamisligil, 2005; Almaguel et al., 2009; Kourtidis et al., 2009) . In the present study, it was found that p-JNK expression was significantly increased in NSCs on treatment with PA at different doses or duration. To further confirm the involvement of JNK pathway in the apoptosis of NSCs by PA, JNK specific inhibitor SP600125 was used to inhibit the JNK activity before PA treatment. It was found that apoptosis and apoptotic-associated proteins of NSCs induced by PA treatment were partially attenuated. These results suggest that PA-induced apoptosis of NSCs is JNK-dependent, and that JNK might be a potential drug target for improving brain abnormalities caused by elevated FFA level.
It is noteworthy that the expression levels of p-p38 and p-ERK1/2 remained relatively unchanged in spite of the increasing dose or time of PA treatment. p-38 kinases are well-recognized in apoptosis, development, differentiation and cell cycle regulation caused by stress stimuli and cytokines (Coulthard et al., 2009) , while ERK1/2 transfer extracellular signals into cellular nucleus by receptor-mediated way and mainly function in cell growth, proliferation and differentiation (Kim and Choi, 2010) . Therefore, our data suggest that p38 and ERK1/2 pathways may not participate in the apoptosis of NSCs induced by PA. Interestingly, p38 kinases have been suggested in the apoptosis of PA in many other cell types (Jiang et al., 2010; Chai and Liu, 2007) . The differential expression of p38 as demonstrated in our study suggests that p38 activation may depend on a variety of factors, such as cell type, cell status and the external stimuli.
In this study, we have employed mouse NSCs rather than human NSCs to explore the effects of PA. In view of this, further study would be desirable to ascertain if comparable effects of PA occur in human NSCs. In addition, elevated FFA level is intimately associated with oxidative stress and high level of ROS. Therefore, the roles of oxidative stress in the activation and regulation of JNK and its specific effect on downstream associated transcription factors are worth pursuing in PA-induced apoptosis of NSCs. It is also desirable to extend the study in vivo such as to feed the mice with high fat diet for further exploration of the possible association between elevation of FFAs and brain disorders. In summary, this study has demonstrated that PA can induce apoptosis of NSCs that is mediated via JNK signaling. It is speculated that this might be one of possible mechanisms contributing to the increased incidence of neurological disorders caused by elevation of FFAs. In light of this, lowering plasma FFA level to normal level, through adjustment of diets and/or application of some potential drugs, may be beneficial to avoid unnecessary neuropsychopathic symptoms and brain abnormalities.
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